An official website of the United States government
Event Details
Description of Event
April 21, 2022
On Friday, May 13, 2022, the National Institute on Deafness and Other Communication Disorders (NIDCD) will hold a symposium honoring Carter Van Waes, M.D., Ph.D. , clinical director of the NIDCD and chief of the NIDCD Head and Neck Surgery Branch, Tumor Biology Section. The day-long symposium will highlight the impact Dr. Van Waes has had on the NIDCD clinical program and the critical contributions he has made to head and neck cancer research. Dr. Van Waes will retire in July.
The virtual symposium will be open to all. Live captioning will be available. Limited in-person attendance ( RSVP required ) is available for NIH staff only.
- What: A symposium in celebration of the career of Carter Van Waes, M.D., Ph.D.
- When: Friday, May 13, 2022, from 9:30 a.m. to 4:15 p.m.
- Where: Virtual. (Limited in-person attendance is open to NIH staff only. RSVP required .) For questions or reasonable accommodation requests, contact Elyssa Monzack, Ph.D. , NIDCD deputy scientific director.
Agenda
| Time | Presentation |
|---|---|
| 9:30 a.m. | Welcome and introduction Debara Tucci, M.D., M.S., M.B.A. Director, NIDCD Lisa Cunningham, Ph.D. Scientific Director, NIDCD |
| 9:45-10:00 a.m. | John Sunwoo, M.D. Stanford University Innate Lymphoid Cells in Head and Neck Cancer |
| 10:05-10:20 a.m. | Anil Lalwani, M.D. Columbia University Opening the Window for Precision Inner Ear Medicine |
| 10:25-10:40 a.m. | Frank Ondrey, M.D., Ph.D. University of Minnesota A Road to Cancer Translational Chemoprevention |
| 10:45-11:00 a.m. | Daniel Choo, M.D. University of Cincinnati The Confluence of Science and Surgery in the Next Era of Otology |
| 11:05-11:20 a.m. | Break |
| 11:20-11:35 a.m. | Zhong Chen, M.D., Ph.D. National Institute of Dental and Craniofacial Research A 28 Year Journey in Head and Neck Cancer Research—from NIDCD to NIDCR |
| 11:40-11:55 a.m. | Gang Dong, M.D., Ph.D. National Institute of Allergy and Infectious Diseases A Head and Neck Cancer Biologist to a NIAID Program Administrator |
| Noon-12:15 p.m. | Michael Hoa, M.D. NIDCD Of Mice and Humans: Investigations into Hearing Instability Disorders |
| 12:20-12:35 p.m. | Wade Chien, M.D. NIDCD Development of Gene Therapy as a Treatment for Hearing Loss and Dizziness |
| 12:40-1:40 p.m. | Lunch (kindly provided by the Van Waes family) |
| 1:40-1:55 p.m. | Anthony Saleh, Ph.D. miRecule Discovery and Development of a MicroRNA Therapeutic for the Treatment of Multi-Drug Resistant Head and Neck Cancer |
| 2:00-2:15 p.m. | Nicole Schmitt, M.D. Emory University IAP Antagonists for Head and Neck Cancer |
| 2:20-2:35 p.m. | Clint Allen, M.D. NIDCD Neoadjuvant Immunotherapy for HNSCC at the NIH: How CVW Helped Make it Happen |
| 2:40-2:55 p.m. | Nyall London Jr., M.D., Ph.D. NIDCD Olfactory Neuroblastoma: The Surgeon-Scientist Perspective |
| 3:00-3:15 p.m. | Andrew Griffith, M.D., Ph.D. University of Tennessee The Puzzle of Human Hereditary Hearing Loss: 25 Years of Finding the Pieces and Putting them Together at NIDCD |
| 3:20-3:30 p.m. | Break |
| 3:30-4:15 p.m. | Closing Remarks Carter Van Waes, M.D., Ph.D. Clinical Director, NIDCD |
| 4:15-4:30 p.m. | Attendee questions/comments |
Virtual. Limited in-person attendance is open to NIH staff only; RSVP required .